Fusion Pharmaceuticals Announces Inducement Grants Beneath Nasdaq Listing Rule 5635(c)(4)
HAMILTON, ON and BOSTON, July 7, 2022 /PRNewswire/ -- Fusion Prescribed drugs Inc. (Nasdaq: FUSN), a clinical-phase oncology enterprise targeted...
HAMILTON, ON and BOSTON, July 7, 2022 /PRNewswire/ -- Fusion Prescribed drugs Inc. (Nasdaq: FUSN), a clinical-phase oncology enterprise targeted...
Tonix Prescribed drugs Holding Corp.CHATHAM, N.J., June 02, 2022 (Globe NEWSWIRE) -- Tonix Prescription drugs Keeping Corp. (Nasdaq: TNXP), a...
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |